Event Type
Disclosure
Voluntary
Variant
8-K
. Other Events. On January 8, 2026, Jasper Therapeutics, Inc. (the “Company”) issued a press release reporting positive updated clinical data from the Company’s
. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release, dated January 8, 2026. 99.2 Presentation – Jasper Therapeutics –